Dr. Byerly has focused on studying the efficacy and effectiveness of psychosocial and pharmacologic interventions of persons with schizophrenia
Head-to-head comparisons of the efficacy and side effects of newer antipsychotics
Phenomenology of antipsychotic non-adherence, and psychosocial interventions to improve antipsychotic non-adherence
RECENT PUBLICATIONS
Byerly M, Lescouflair E, Carmody T, Weber M, Holland R, Fisher R., "An Open-Label Trial of Quetiapine for Antipsychotic-Induced Sexual Dysfunction" Submitted to Schiz Bull,
SIGNIFICANT PUBLICATIONS
Montgomery J, Byerly MJ, Carmody T, Li G, Varghese F, Holland R., "Industry Sponsored Research Involving Newer Antipsychotic Agents for the Treatment of Schizophrenia: Does Source of Funding Influence Design and Outcome?" Submitted to Schiz Bull,
Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick I, Canive J, McGee M, Simpson G, Stevens M, Lieberman JA., "The NIMH-CATIE Project: Schizophrenia Trial Design and Protocol Development" Schiz Bull. In press,
Byerly M, Weber M, Brooks D, Casey SB, Elliot S, Cross J, McConnell D, Hawkins J., "Cost Evaluation of Risperidone Versus Olanzapine: A Database and Chart Review Study" Psychiatr Serv, 54/5:742-744, 2003
Byerly MJ, Weber M, Snow L, Worley M, Lescouflair E., "Antipsychotic Medications and the Elderly: Effects on Cognition and Implications for Use" Drugs and Aging, 18:45-61, 2001
Point and right click (click and hold for Mac users) your mouse onand select "Save this link (or target) as..." option to save the file to your local computer.
and select "Save this link (or target) as..." option to save the file to your local computer.